GASTROINTESTINAL AND GENITOURINARY COMORBIDITIES IN PARKINSON’S DISEASE PATIENTS
Abstract:
A clinical, cross-sectional, observational study has been performed on a group of 86 consecutive patients with idiopathic Parkinson’s disease (PD). The patients and their caregivers have been asked about disease duration, associated medical conditions and current medications. The overall assessed prevalence of gastrointestinal co-morbidities is 46,51% (95% CI 35.9-57); genitourinary co-morbidities have been identified in 31.39% (95%CI 21.5-41.2) of the interviewed patients. The most prevalent gastrointestinal co-morbidities were chronic gastritis/gastro-duodenitis 16.27% (95%CI 8.47-24.07), chronic constipation 8.13 % (95%CI 2.35-13.91), gastric / duodenal ulcer 4.65% (95% CI 0.2-9.1). Among genitourinary co-morbidities, benign prostatic hyperplasia ranked first 16.27% (95%CI 8.47-24.07), followed by recurrent urinary tract infection 9.3% (95%CI 3.16-15.44) and renal lithiasis 3.48% (95%CI 0-7.35). A statistically significant superior proportion of the women with PD included in this study reported gastrointestinal co-morbidities compared to men. No statistically significant difference was noticed between men and women PD patients regarding the prevalence of genitourinary co-morbidities
full text article in English (.EN) |